FeesSafety
Pluang+

New home sales in Ontario jump 61% in Q3 2026, driven by enhanced HST rebate program.

Market News
03 Nov 2026, 17:10 WIB
Globe News Wire
View Source
Bullish
New home sales in Ontario jump 61% in Q3 2026, driven by enhanced HST rebate program.

New home sales in Ontario surged 61% year-over-year in Q3 2026, reaching 7,914 units, fueled by the provincial-federal enhanced HST rebate program launched in April 2026. This program has boosted affordability, sustained skilled jobs, and stimulated economic activity, with nearly 3,000 additional sales attributed directly to the rebate. From April to September, total new home sales nearly doubled compared to 2025, protecting around 27,800 construction jobs and preserving $4.4 billion in GDP. The positive momentum is expected to continue, supporting homeownership and economic growth in Ontario.

New home sales in Ontario provide context for real estate sector trends. For readers following real estate stocks, here is Pluang's market snapshot as of Nov 03, 2026 21:22 WIB: Among 47 priced US real estate stocks, 24 rose and 20 fell. Notable movers include AMH at USD 31.63 with a -0.82% change, BRX at USD 29.80 with +0.81%, and OHI at USD 47.37 with +0.79% and 100% buy order activity on Pluang.

More News

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

The global Automatic FOUP Opener Market is projected to grow from USD 4.41 billion in 2026 to USD 6.04 billion by 2032, expanding at a CAGR of 5.36%. Growth is driven by increasing fab automation, stricter contamination control requirements, and dema...

Market News
Bullish
37 minutes ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
3 hours ago
Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
3 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
3 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App